Dolby Laboratories (DLB) Liabilities and Shareholders Equity (2016 - 2026)
Quarterly Liabilities and Shareholders Equity rose 0.63% to $3.2 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $12.9 billion through Mar 2026, up 3.16% year-over-year, with the annual reading at $3.2 billion for FY2025, 3.79% up from the prior year.
Dolby Laboratories filings provide 18 years of Liabilities and Shareholders Equity readings, the most recent being $3.2 billion for Q1 2026.
- Liabilities and Shareholders Equity hit $3.2 billion in Q1 2026 for Dolby Laboratories, up from $3.2 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $3.2 billion in Q1 2026 and bottomed at $2.7 billion in Q3 2022.
- Average Liabilities and Shareholders Equity over 5 years is $3.0 billion, with a median of $3.0 billion recorded in 2024.
- The largest annual shift saw Liabilities and Shareholders Equity fell 13.4% in 2022 before it grew 10.79% in 2023.
- Dolby Laboratories' Liabilities and Shareholders Equity stood at $2.7 billion in 2022, then increased by 6.8% to $2.9 billion in 2023, then rose by 7.6% to $3.2 billion in 2024, then rose by 1.06% to $3.2 billion in 2025, then grew by 1.8% to $3.2 billion in 2026.
- Per Business Quant, the three most recent readings for DLB's Liabilities and Shareholders Equity are $3.2 billion (Q1 2026), $3.2 billion (Q4 2025), and $3.2 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Relx | 81.40 Bn | 81.16 Bn | - | 19.63 Bn |
| 2 | Rentokil Initial | 79.56 Bn | 78.10 Bn | - | 78.00 Mn |
| 3 | Cintas | 69.26 Bn | 69.08 Bn | 1.45 Bn | 10.23 Bn |
| 4 | Copart | 33.09 Bn | 28.01 Bn | 971.24 Mn | 10.59 Bn |
| 5 | UL Solutions | 20.56 Bn | 20.32 Bn | 381.00 Mn | 2.96 Bn |
| 6 | Global Payments | 19.88 Bn | 14.69 Bn | 1.70 Bn | 64.25 Bn |
| 7 | Rb Global | 19.08 Bn | 18.89 Bn | 869.50 Mn | 12.40 Bn |
| 8 | Aramark | 13.57 Bn | 13.16 Bn | 426.35 Mn | 13.84 Bn |
| 9 | Amentum Holdings | 5.65 Bn | 5.74 Bn | 345.00 Mn | 11.17 Bn |
| 10 | Dolby Laboratories | 5.15 Bn | 4.56 Bn | 350.90 Mn | 3.25 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 27, 2026 | 3.25 Bn |
| Dec 26, 2025 | 3.19 Bn |
| Sep 26, 2025 | 3.23 Bn |
| Jun 27, 2025 | 3.20 Bn |
| Mar 28, 2025 | 3.23 Bn |
| Dec 27, 2024 | 3.16 Bn |
| Sep 27, 2024 | 3.11 Bn |
| Jun 28, 2024 | 2.97 Bn |
| Mar 29, 2024 | 3.04 Bn |
| Dec 29, 2023 | 2.94 Bn |
| Sep 29, 2023 | 2.98 Bn |
| Jun 30, 2023 | 3.01 Bn |
| Mar 31, 2023 | 2.84 Bn |
| Dec 30, 2022 | 2.75 Bn |
| Sep 30, 2022 | 2.69 Bn |
| Jul 1, 2022 | 2.92 Bn |
| Apr 1, 2022 | 3.06 Bn |
| Dec 31, 2021 | 3.10 Bn |
| Sep 24, 2021 | 3.11 Bn |
| Jun 25, 2021 | 3.14 Bn |
| Mar 26, 2021 | 3.11 Bn |
| Dec 25, 2020 | 3.10 Bn |
| Sep 25, 2020 | 2.92 Bn |
| Jun 26, 2020 | 2.90 Bn |
| Mar 27, 2020 | 2.94 Bn |
| Dec 27, 2019 | 2.89 Bn |
| Sep 27, 2019 | 2.82 Bn |
| Jun 28, 2019 | 2.81 Bn |
| Mar 29, 2019 | 2.85 Bn |
| Dec 28, 2018 | 2.82 Bn |
| Sep 28, 2018 | 2.87 Bn |
| Jun 29, 2018 | 2.67 Bn |
| Mar 30, 2018 | 2.61 Bn |
| Dec 29, 2017 | 2.51 Bn |
| Sep 29, 2017 | 2.53 Bn |
| Jun 30, 2017 | 2.47 Bn |
| Mar 31, 2017 | 2.39 Bn |
| Dec 30, 2016 | 2.33 Bn |
| Sep 30, 2016 | 2.31 Bn |
| Jul 1, 2016 | 2.26 Bn |